Heart-targeted adeno-associated viral vectors selected by in vivo biopanning of a random viral display peptide library (Q33555864)

28 July 2017

title

Heart-targeted adeno-associated viral vectors selected by in vivo biopanning of a random viral display peptide library (English)

1 reference

28 July 2017

H A Katus

1 reference

28 July 2017

Y Ying

1 reference

28 July 2017

O J Müller

1 reference

28 July 2017

C Goehringer

1 reference

28 July 2017

B Leuchs

1 reference

28 July 2017

M Trepel

1 reference

28 July 2017

J A Kleinschmidt

1 reference

28 July 2017

publication date

15 April 2010

1 reference

28 July 2017

1 reference

28 July 2017

1 reference

28 July 2017

1 reference

28 July 2017

page(s)

980-990

1 reference

Custom adeno-associated virus capsids: the next generation of recombinant vectors with novel tropism

28 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.44

Transductional targeting of adenovirus vectors for gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.44

Ligand-directed targeting of genes to the site of disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.44

Transcriptionally targeted adenovirus vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.44

Endogenous microRNA regulation suppresses transgene expression in hematopoietic lineages and enables stable gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.44

Receptor targeting of adeno-associated virus vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.44

DNA shuffling of adeno-associated virus yields functionally diverse viral progeny

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.44

In vitro and in vivo gene therapy vector evolution via multispecies interbreeding and retargeting of adeno-associated viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.44

Engineering and selection of shuffled AAV genomes: a new strategy for producing targeted biological nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.44

New recombinant serotypes of AAV vectors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.44

Targeted adeno-associated virus vector transduction of nonpermissive cells mediated by a bispecific F(ab'gamma)2 antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.44

Conjugate-based targeting of recombinant adeno-associated virus type 2 vectors by using avidin-linked ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.44

Metabolic biotinylation provides a unique platform for the purification and targeting of multiple AAV vector serotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.44

Adeno-associated virus capsids displaying immunoglobulin-binding domains permit antibody-mediated vector retargeting to specific cell surface receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.44

Altering AAV tropism with mosaic viral capsids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.44

Genetic capsid modifications allow efficient re-targeting of adeno-associated virus type 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.44

Combinatorial engineering of a gene therapy vector: directed evolution of adeno-associated virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.44

Directed evolution of adeno-associated virus yields enhanced gene delivery vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.44

Adeno-associated virus type 2 VP2 capsid protein is nonessential and can tolerate large peptide insertions at its N terminus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.44

Green fluorescent protein-tagged adeno-associated virus particles allow the study of cytosolic and nuclear trafficking

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.44

Targeting recombinant adeno-associated virus vectors to enhance gene transfer to pancreatic islets and liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.44

Insertional mutagenesis of the adeno-associated virus type 2 (AAV2) capsid gene and generation of AAV2 vectors targeted to alternative cell-surface receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.44

Mutational analysis of the adeno-associated virus type 2 (AAV2) capsid gene and construction of AAV2 vectors with altered tropism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.44

Development of novel cell surface CD34-targeted recombinant adenoassociated virus vectors for gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.44

Identification of a heparin-binding motif on adeno-associated virus type 2 capsids

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.44

Identification of amino acid residues in the capsid proteins of adeno-associated virus type 2 that contribute to heparan sulfate proteoglycan binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.44

Incorporation of tumor-targeting peptides into recombinant adeno-associated virus capsids

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.44

RGD inclusion in VP3 provides adeno-associated virus type 2 (AAV2)-based vectors with a heparan sulfate-independent cell entry mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.44

Targeted gene delivery to vascular tissue in vivo by tropism-modified adeno-associated virus vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.44

Development of efficient viral vectors selective for vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.44

Efficient and selective AAV2-mediated gene transfer directed to human vascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.44

In vitro selection of viral vectors with modified tropism: the adeno-associated virus display

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.44

Random peptide libraries displayed on adeno-associated virus to select for targeted gene therapy vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.44

Isolation of targeted AAV2 vectors from novel virus display libraries

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.44

Altering retroviral tropism using a random-display envelope library

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.44

Probing sequence variation in the receptor-targeting domain of feline leukemia virus envelope proteins with peptide display libraries

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.44

Improved cardiac gene transfer by transcriptional and transductional targeting of adeno-associated viral vectors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.44

Robust systemic transduction with AAV9 vectors in mice: efficient global cardiac gene transfer superior to that of AAV8.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.44

Successful expansion but not complete restriction of tropism of adeno-associated virus by in vivo biopanning of random virus display peptide libraries

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.44

Systemic delivery of genes to striated muscles using adeno-associated viral vectors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.44

Unrestricted hepatocyte transduction with adeno-associated virus serotype 8 vectors in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.44

Efficacy of an adeno-associated virus 8-pseudotyped vector in glycogen storage disease type II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.44

Recombinant adeno-associated virus serotype 9 leads to preferential cardiac transduction in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.44

Analysis of AAV serotypes 1-9 mediated gene expression and tropism in mice after systemic injection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.44

A myocardium tropic adeno-associated virus (AAV) evolved by DNA shuffling and in vivo selection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.44

Genetic modifications of the adeno-associated virus type 2 capsid reduce the affinity and the neutralizing effects of human serum antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.44

Sustained whole-body functional rescue in congestive heart failure and muscular dystrophy hamsters by systemic gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.44

Helper virus-free, optically controllable, and two-plasmid-based production of adeno-associated virus vectors of serotypes 1 to 6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.44

Rapid and highly efficient transduction by double-stranded adeno-associated virus vectors in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.44

Clades of Adeno-associated viruses are widely disseminated in human tissues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.44

Development and optimization of a real-time quantitative PCR-based method for the titration of AAV-2 vector stocks

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.44

Gene therapy progress and prospects--vectorology: design and production of expression cassettes in AAV vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.44

7 January 2021

Engineering and Selection of Shuffled AAV Genomes: A New Strategy for Producing Targeted Biological Nanoparticles

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.44

7 January 2021

A Hybrid Vector for Ligand-Directed Tumor Targeting and Molecular Imaging

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.44

7 January 2021

A "humanized" green fluorescent protein cDNA adapted for high-level expression in mammalian cells

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.44

7 January 2021

Production and purification of recombinant adeno-associated virus

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.44

7 January 2021

Identifiers

DOI

10.1038/GT.2010.44

1 reference

28 July 2017

1 reference